{"id":85597,"date":"2026-06-16T21:07:03","date_gmt":"2026-06-16T21:07:03","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/85597\/"},"modified":"2026-06-16T21:07:03","modified_gmt":"2026-06-16T21:07:03","slug":"roche-chairman-still-expects-diagnostics-hit-from-us-tariffs-5","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/85597\/","title":{"rendered":"Roche chairman still expects diagnostics hit from US tariffs"},"content":{"rendered":"<p>ZURICH, March 7 (Reuters) &#8211; Roche <a data-testid=\"Link\" target=\"_blank\" referrerpolicy=\"no-referrer-when-downgrade\" href=\"https:\/\/www.reuters.com\/markets\/companies\/ROG.S\" rel=\"noopener nofollow\" class=\"text-module__text__0GDob text-module__inherit-color__PhuPF text-module__inherit-font__1P1hv text-module__inherit-size__EyiQW link-module__link__INqxZ link-module__underline_default__-okuC link-module__with-icon__qlg76\">(ROG.S), opens new tab<\/a> expects its agreement with the U.S. government will keep its medicines exempt from the current round of \u200bimport tariffs, but its diagnostics division remains exposed and \u200ccould face renewed duties after an initial 150-day period, Chairman Severin Schwan said on Saturday.Roche was one of nine major pharmaceutical companies that \u200bagreed a deal with U.S. President Donald Trump in <a data-testid=\"Link\" referrerpolicy=\"no-referrer-when-downgrade\" href=\"https:\/\/www.reuters.com\/legal\/litigation\/several-top-drugmakers-lower-us-prices-some-drugs-sources-2025-12-19\/\" class=\"text-module__text__0GDob text-module__inherit-color__PhuPF text-module__inherit-font__1P1hv text-module__inherit-size__EyiQW link-module__link__INqxZ link-module__underline_default__-okuC\" rel=\"nofollow noopener\" target=\"_blank\">December<\/a> \u200bto cut the prices of their medicines in \u2060return for removing the threat of tariffs for three years.<\/p>\n<p data-testid=\"promo-box\" class=\"text-module__text__0GDob text-module__dark-grey__UFC18 text-module__regular__qJJtA text-module__small__sph8i body-module__base__o--Cl body-module__small_body__gOmDf article-body-module__promo-box__hVl8h\"> Sign up  <a data-testid=\"Link\" referrerpolicy=\"no-referrer-when-downgrade\" href=\"https:\/\/www.reuters.com\/business\/healthcare-pharmaceuticals\/roche-chairman-still-expects-diagnostics-hit-us-tariffs-2026-03-07\/undefined?location=article-paragraph&amp;redirectUrl=%2Fbusiness%2Fhealthcare-pharmaceuticals%2Froche-chairman-still-expects-diagnostics-hit-us-tariffs-2026-03-07%2F\" class=\"text-module__text__0GDob text-module__inherit-color__PhuPF text-module__inherit-font__1P1hv text-module__inherit-size__EyiQW link-module__link__INqxZ link-module__underline_default__-okuC\" rel=\"nofollow noopener\" target=\"_blank\">here.<\/a><\/p>\n<p>&#8220;As \u200bfar as pharmaceuticals are concerned, we assume our agreement with the \u200bgovernment is binding and that we will continue to be exempt from tariffs on the import of medicines,&#8221; Schwan told Swiss newspaper Neue Zuercher \u200bZeitung.<\/p>\n<p>&#8220;But our diagnostics business continues to be significantly affected,&#8221; \u200bhe added.<\/p>\n<p>Roche&#8217;s diagnostics division, which generated sales of nearly 14 billion Swiss francs \u200cin \u20602025, exported a large share of its tests and instruments from Switzerland and other European countries to the United States, Schwan said.<\/p>\n<p>Roche also produced diagnostics products in the U.S., which \u200bfaced import tariffs \u200bfrom China, he \u2060said.<\/p>\n<p>&#8220;But because China has introduced retaliatory tariffs, we end up, as a U.S. net exporter, \u200bpaying tariffs twice. That&#8217;s absurd,&#8221; he said.<\/p>\n<p>Schwan said \u200bhe \u2060expected the U.S. government to impose import tariffs again under a different legal basis after the 150-day limit on tariffs expires.<\/p>\n<p>Roche had \u2060no \u200bplans to split off its diagnostics \u200bdivision, he said. &#8220;That is not a topic at all. We are sticking with \u200bit,&#8221; he told the newspaper.<\/p>\n<p data-testid=\"SignOff\" class=\"text-module__text__0GDob text-module__dark-grey__UFC18 text-module__regular__qJJtA text-module__extra_small__8Buss body-module__full_width__kCIGb body-module__extra_small_body__Bfz20 sign-off-module__text__LQAMP\">Reporting by John Revill<br \/>\nEditing by Tomasz Janowski<\/p>\n<p data-testid=\"Body\" dir=\"ltr\" class=\"text-module__text__0GDob text-module__dark-grey__UFC18 text-module__regular__qJJtA text-module__small__sph8i body-module__base__o--Cl body-module__small_body__gOmDf article-body-module__element__5eCce article-body-module__trust-badge__5mS3f\">Our Standards: <a data-testid=\"Link\" target=\"_blank\" referrerpolicy=\"no-referrer-when-downgrade\" href=\"https:\/\/www.thomsonreuters.com\/en\/about-us\/trust-principles.html\" rel=\"noopener nofollow\" class=\"text-module__text__0GDob text-module__dark-grey__UFC18 text-module__medium__2Rl30 text-module__small__sph8i link-module__link__INqxZ link-module__underline_default__-okuC link-module__with-icon__qlg76\">The Thomson Reuters Trust Principles., opens new tab<\/a><\/p>\n<p><a href=\"https:\/\/www.reutersagency.com\/en\/licensereuterscontent\/?utm_medium=rcom-article-media&amp;utm_campaign=rcom-rcp-lead\" target=\"_blank\" dir=\"ltr\" class=\"button-module__link__A3sD0 button-module__secondary__70gBu button-module__round__QDFgq button-module__w_auto__Sem-F\" data-testid=\"LicenceContentButton\" rel=\"nofollow noopener\">Purchase Licensing Rights<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"ZURICH, March 7 (Reuters) &#8211; Roche (ROG.S), opens new tab expects its agreement with the U.S. government will&hellip;\n","protected":false},"author":2,"featured_media":85598,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[124],"tags":[18218,15523,15524,15513,15530,15528,15529,18220,21529,43658,32532,2082,787,10873,15525,2228,15515,43659,26133,32534,10867,10866,18219,21530,15517,15518,15519,21532,21533,15521,134,32310,18230,32311,43660,32312,32313,714,21534,10872],"class_list":["post-85597","post","type-post","status-publish","format-standard","has-post-thumbnail","category-roche","tag-amers","tag-ceeu","tag-ch","tag-cmpny","tag-destocabsm","tag-destoukbsm","tag-destousbsm","tag-destoushem","tag-dip","tag-eci","tag-eco","tag-emea","tag-eu","tag-europ","tag-fin","tag-gen","tag-heca","tag-hrep","tag-intag","tag-mce","tag-mtpix","tag-mtvid","tag-namer","tag-news1","tag-phar","tag-phar1","tag-phmr","tag-pol","tag-potus","tag-publ","tag-roche","tag-rulestrump","tag-topcmb","tag-topicbusiness-tariffs","tag-tracc","tag-trd","tag-trf","tag-us","tag-wash","tag-weu"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/116761830740283169","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/85597","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=85597"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/85597\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/85598"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=85597"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=85597"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=85597"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}